|
Parameters
|
mean
|
sd
|
2.5%
|
97.5%
|
|---|
|
α 1
|
4.91*
|
0.71
|
3.61
|
6.42
|
|
α 2
|
5.77*
|
0.72
|
4.45
|
7.29
|
|
γ S 3 (Study 3-1)
|
0.246
|
0.537
|
-0.742
|
1.371
|
|
γ S 4 (Study 4-1)
|
0.572
|
0.584
|
−0.547
|
1.719
|
|
γ S 5 (Study 5-1)
|
−0.505
|
0.367
|
−1.216
|
0.222
|
|
γ 2 (AQ)
|
−0.402
|
0.434
|
−1.218
|
0.481
|
|
γ 3 (AMLM)
|
1.212
|
0.936
|
−0.443
|
3.24
|
|
γ 4 (ASCD)
|
−1.514*
|
0.682
|
−2.85
|
−0.186
|
|
γ 5 (ASSP)
|
−0.109
|
0.465
|
−0.989
|
0.844
|
|
γ 6 (DHPP)
|
2.353*
|
0.852
|
0.924
|
4.288
|
|
γ D 21 (Day 21–14)
|
−2.121*
|
0.459
|
−3.112*
|
−1.298
|
|
γ D 28 (Day 28–14)
|
−2.036*
|
0.467
|
−3.030*
|
−1.194
|
|
Weight
|
0.218
|
0.360
|
−0.478
|
0.933
|
|
Gender
|
−0.154
|
0.234
|
−0.615
|
0.298
|
|
Age
|
0.189
|
0.505
|
−0.896
|
1.067
|
|
Parasitaemia Day 0
|
−0.171
|
0.352
|
−0.872
|
0.506
|
|
Parasitaemia Day 3
|
0.085
|
0.669
|
−1.083
|
1.542
|
|
Expected children
|
795
|
746
|
732
| |
|
Missing
|
49
|
14
|
59
|
122 (15)
|
|
Fully observed
|
746
|
732
|
687
| |
- sd: standard deviation, 2.5% and 97.5% : percentiles of the posterior distributions. Study reference: Study 1; Treatment reference: ASAQ; Day reference: Day 14. *: significant effect at the 0.05% level.
